Mass spectrometry and DigiWest technology emphasize protein acetylation profile from Quisinostat-treated HuT78 CTCL cell line (original) (raw)
Quantitative Acetylomics Uncover Acetylation-Mediated Pathway Changes Following Histone Deacetylase Inhibition in Anaplastic Large Cell Lymphoma
Lisa Winkelmayer
Cells
View PDFchevron_right
Quantitative proteomic analysis of post-translational modifications of human histones
Hans Beck, Rune Matthiesen
Molecular & Cellular …, 2006
View PDFchevron_right
Directing The Role of Histone Deacetylase Inhibitors in Cancer Therapy: A Review
Bhavini Gharia
2019
View PDFchevron_right
A proteomic approach for evaluating the cell response to a novel histone deacetylase inhibitor in colon cancer cells
Anna Maria Timperio
2008
View PDFchevron_right
Molecular and Biologic Analysis of Histone Deacetylase Inhibitors with Diverse Specificities
Saverio Minucci
Molecular Cancer Therapeutics, 2013
View PDFchevron_right
Quantitative Proteomic Analysis of Histone Modifications
Benjamín García
Chemical reviews, 2015
View PDFchevron_right
Prognostic significance of the therapeutic targets histone deacetylase 1, 2, 6 and acetylated histone H4 in cutaneous T-cell lymphoma
Lise Gjerdrum
Histopathology, 2008
View PDFchevron_right
Differential sensitivity of human leukemic cell lines to the histone deacetylase inhibitor, trichostatin A
Yiannis Ninios
View PDFchevron_right
Histone deacetylases and epigenetic therapies of hematological malignancies
Ciro Mercurio
Pharmacological research : the official journal of the Italian Pharmacological Society, 2010
View PDFchevron_right
The combination of hypomethylating agents and histone deacetylase inhibitors produce marked synergy in preclinical models of T-cell lymphoma
Owen O'Connor
British Journal of Haematology, 2015
View PDFchevron_right
Targeting histone deacetyalses in the treatment of B- and T-cell malignancies
Jasmine Zain
Investigational New Drugs, 2010
View PDFchevron_right
Proteome analyses of the growth inhibitory effects of NCH-51, a novel histone deacetylase inhibitor, on lymphoid malignant cells
Takashi Okamoto
Leukemia, 2007
View PDFchevron_right
Targeting histone deacetylase in cancer therapy
Chang-shi Chen
Medicinal Research Reviews, 2006
View PDFchevron_right
Differential protein acetylation induced by novel histone deacetylase inhibitors
Keith Glaser
Biochemical and Biophysical Research Communications, 2004
View PDFchevron_right
Histone Deacetylase Inhibitors: A New Wave of Molecular Targeted Anticancer Agents
Alfredo Budillon
Recent Patents on Anti-Cancer Drug Discovery, 2007
View PDFchevron_right
Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability
Christine Tam
Journal of Biological Chemistry, 2013
View PDFchevron_right
Quantitative proteomics to characterize specific histone H2A proteolysis in chronic lymphocytic leukemia and the myeloid THP-1 cell line
Maarten Dhaenens
International journal of molecular sciences, 2014
View PDFchevron_right
Current perspective of histone deacetylase inhibitors: A review
IP Innovative Publication Pvt. Ltd.
IP Innovative Publication Pvt. Ltd., 2018
View PDFchevron_right
Histone deacetylase inhibitors globally enhance h3/h4 tail acetylation without affecting h3 lysine 56 acetylation
Alain Verreault
Scientific reports, 2012
View PDFchevron_right
Efficacy of novel histone deacetylase inhibitor, AR42, in a mouse model of, human T-lymphotropic virus type 1 adult T cell lymphoma
Michael Lairmore
Leukemia Research - LEUK RES, 2011
View PDFchevron_right
Histone Deacetylase Inhibitors: Emerging Mechanisms of Resistance
Victoria Luchenko
Molecular Pharmaceutics, 2011
View PDFchevron_right
Histone Deacetylase Inhibitor Pharmacodynamic Analysis by Multiparameter Flow Cytometry
Judith Karp
Annals of Clinical and Laboratory Science, 2005
View PDFchevron_right
Histone Deacetylase Inhibitors in Cancer Therapy: Latest Developments, Trends and Medicinal Chemistry Perspective
Andrew Lane
Anti-Cancer Agents in Medicinal Chemistry, 2007
View PDFchevron_right
Site-specific quantification of lysine acetylation in the N-terminal tail of histone H4 using a double-labelling, targeted UHPLC MS/MS approach
Annalisa D'Urzo
Analytical and bioanalytical chemistry, 2016
View PDFchevron_right
Histone deacetylase inhibitor-mediated cell death is distinct from its global effect on chromatin
Thomas Litman
Molecular oncology, 2014
View PDFchevron_right